These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 19958570)

  • 1. Deficits in the automatic activation of religious concepts in patients with Parkinson's disease.
    Butler PM; McNamara P; Durso R
    J Int Neuropsychol Soc; 2010 Mar; 16(2):252-61. PubMed ID: 19958570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summation of semantic priming and complex sentence comprehension in Parkinson's disease.
    Angwin AJ; Chenery HJ; Copland DA; Murdoch BE; Silburn PA
    Brain Res Cogn Brain Res; 2005 Sep; 25(1):78-89. PubMed ID: 15894470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of dopamine on semantic activation in Parkinson's disease: evidence from a multipriming task.
    Angwin AJ; Copland DA; Chenery HJ; Murdoch BE; Silburn PA
    Neuropsychology; 2006 May; 20(3):299-306. PubMed ID: 16719623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.
    Fera F; Nicoletti G; Cerasa A; Romeo N; Gallo O; Gioia MC; Arabia G; Pugliese P; Zappia M; Quattrone A
    Brain Res Bull; 2007 Sep; 74(1-3):75-83. PubMed ID: 17683792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spreading activation of lexical-semantic networks in Parkinson's disease.
    Foster PS; Drago V; FitzGerald DB; Skoblar BM; Crucian GP; Heilman KM
    Neuropsychologia; 2008; 46(7):1908-14. PubMed ID: 18325544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
    Tomer R; Aharon-Peretz J; Tsitrinbaum Z
    Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's disease.
    Stebbins GT; Gabrieli JD; Shannon KM; Penn RD; Goetz CG
    Brain Cogn; 2000 Apr; 42(3):348-63. PubMed ID: 10753484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-associated differences in religious cognition in patients with Parkinson's disease.
    Butler PM; McNamara P; Ghofrani J; Durso R
    J Clin Exp Neuropsychol; 2011 Oct; 33(8):917-28. PubMed ID: 21656414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semantic and affective priming as a function of stimulation of the subthalamic nucleus in Parkinson's disease.
    Castner JE; Chenery HJ; Copland DA; Coyne TJ; Sinclair F; Silburn PA
    Brain; 2007 May; 130(Pt 5):1395-407. PubMed ID: 17430981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side of onset of motor symptoms influences cognition in Parkinson's disease.
    Tomer R; Levin BE; Weiner WJ
    Ann Neurol; 1993 Oct; 34(4):579-84. PubMed ID: 8215246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered corticomotor representation in patients with Parkinson's disease.
    Kagerer FA; Summers JJ; Byblow WD; Taylor B
    Mov Disord; 2003 Aug; 18(8):919-27. PubMed ID: 12889083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The basal ganglia and semantic engagement: potential insights from semantic priming in individuals with subcortical vascular lesions, Parkinson's disease, and cortical lesions.
    Copland D
    J Int Neuropsychol Soc; 2003 Nov; 9(7):1041-52. PubMed ID: 14738285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain dopaminergic modulation associated with executive function in Parkinson's disease.
    Farid K; Sibon I; Guehl D; Cuny E; Burbaud P; Allard M
    Mov Disord; 2009 Oct; 24(13):1962-9. PubMed ID: 19672989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side of symptom onset affects motor dysfunction in Parkinson's disease.
    Haaxma CA; Helmich RC; Borm GF; Kappelle AC; Horstink MW; Bloem BR
    Neuroscience; 2010 Nov; 170(4):1282-5. PubMed ID: 20723583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prefrontal cortex and striatal activation by feedback in Parkinson's disease.
    Keitz M; Koerts J; Kortekaas R; Renken R; de Jong BM; Leenders KL
    Brain Res; 2008 Oct; 1236():225-33. PubMed ID: 18718454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semantic activation in Parkinson's disease patients on and off levodopa.
    Angwin AJ; Arnott WL; Copland DA; Haire MP; Murdoch BE; Silburn PA; Chenery HJ
    Cortex; 2009 Sep; 45(8):950-9. PubMed ID: 19356748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Working memory dysfunction in obsessive-compulsive disorder: a neuropsychological and functional MRI study.
    Nakao T; Nakagawa A; Nakatani E; Nabeyama M; Sanematsu H; Yoshiura T; Togao O; Tomita M; Masuda Y; Yoshioka K; Kuroki T; Kanba S
    J Psychiatr Res; 2009 May; 43(8):784-91. PubMed ID: 19081580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semantic priming in Parkinson's disease: evidence for delayed spreading activation.
    Arnott WL; Chenery HJ; Murdoch BE; Silburn PA
    J Clin Exp Neuropsychol; 2001 Aug; 23(4):502-19. PubMed ID: 11780949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Object naming and action-verb generation in Parkinson's disease: a fMRI study.
    Péran P; Cardebat D; Cherubini A; Piras F; Luccichenti G; Peppe A; Caltagirone C; Rascol O; Démonet JF; Sabatini U
    Cortex; 2009 Sep; 45(8):960-71. PubMed ID: 19368905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.